SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-002693
Filing Date
2021-01-08
Accepted
2021-01-08 16:01:51
Documents
1
Period of Report
2021-01-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6525
  Complete submission text file 0001209191-21-002693.txt   8014
Mailing Address C/O RUBIUS THERAPEUTICS 399 BINNEY STREET SUITE 300 CAMBRIDGE MA 02139
Business Address
Prener Anne (Reporting) CIK: 0001797917 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39655 | Film No.: 21517471

Mailing Address GALECTO BIOTECH AB OLE MAALOES VEJ3 COPENHAGEN G7 DK-2200
Business Address GALECTO BIOTECH AB OLE MAALOES VEJ3 COPENHAGEN G7 DK-2200 45-70-70-52-10
Galecto, Inc. (Issuer) CIK: 0001800315 (see all company filings)

IRS No.: 371957007 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations